The Challenge
The Antibody Technology Shared Resource at the Fred Hutch Cancer Research Center offers custom antibody development to academic and industrial research groups. Their unique multiplex screening platform incorporates a Molecular Devices ClonePix 2 for identifying and picking monoclonal hybridoma colonies that secrete antibody to specific protein, peptide, or small molecule targets. The ClonePix 2 has allowed them to completely redefine their project workflow and capacity.
ClonePix 2 Mammalian Colony Picker
Products Used
Automatically screen more clones in less time than conventional techniques, select cells with optimal expression levels, and pick colonies with accuracy with the ClonePix® 2 System. ClonePix Systems are now used in over 100 laboratories around the world to increase workflow productivity, leaving more time to better characterize target proteins and run new projects. A large number of biopharma companies have implemented ClonePix Systems in their routine use and data are cited increasingly in scientific publications and conferences.